Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey

被引：0
|
作者：
Andrew Scheibe
Katherine Young
Lorraine Moses
Rudolph L. Basson
Anna Versfeld
C. Wendy Spearman
Mark W. Sonderup
Nishi Prabdial-Sing
Jack Manamela
Adrian J. Puren
Kevin Rebe
Harry Hausler
机构：
[1] TB HIV Care,Division of Hepatology, Department of Medicine, Faculty of Health Sciences
[2] IQVIA South Africa,Division of Virology, School of Pathology
[3] University of Cape Town,undefined
[4] National Institute for Communicable Diseases,undefined
[5] University of the Witwatersrand,undefined
[6] Anova Health Institute,undefined
来源：
Harm Reduction Journal | / 16卷
关键词：
Hepatitis C; Hepatitis B; HIV; HBV; HCV; People who inject drugs; Key populations; South Africa;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Risk of HIV and Hepatitis B and C Over Time Among Men Who Inject Image and Performance Enhancing Drugs in England and Wales: Results From Cross-Sectional Prevalence Surveys, 1992-2013
    Hope, Vivian D.
    Harris, Ross
    McVeigh, Jim
    Cullen, Katelyn J.
    Smith, Josie
    Parry, John V.
    DeAngelis, Daniela
    Ncube, Fortune
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2016, 71 (03) : 331 - 337
  • [22] Prevalence of hepatitis B and anti-hepatitis C virus antibody among people who inject drugs in the Lebanese population
    Abou Rached, Antoine
    Nakhoul, Mary
    Richa, Carine
    Jreij, Afif
    Hanna, Pierre Abi
    Ammar, Walid
    EASTERN MEDITERRANEAN HEALTH JOURNAL, 2020, 26 (04) : 461 - 467
  • [23] A simplified point-of-service model for hepatitis C in people who inject drugs in South Africa
    Saayman, Elaine
    Hechter, Vanessa
    Kayuni, Ndoliwe
    Sonderup, Mark W. W.
    HARM REDUCTION JOURNAL, 2023, 20 (01)
  • [24] Barriers to HIV and Hepatitis C care for people who inject drugs in Colombia
    Borda, Juan P.
    Friedman, Hannah L.
    Castano, Guillermo A.
    Rodriguez, Henry A.
    Munoz, Carlos F.
    Tofighi, Babak
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2022, 34 (05): : 633 - 638
  • [25] WHO guidance on the prevention of viral hepatitis B and C among people who inject drugs Comment
    Walsh, Nick
    Verster, Annette
    Rodolph, Michelle
    Akl, Elie A.
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2014, 25 (03) : 363 - 371
  • [26] HIV and viral hepatitis C coinfection in people who inject drugs: implications of new direct acting antivirals for hepatitis C virus treatment
    Walsh, Nick
    Maher, Lisa
    CURRENT OPINION IN HIV AND AIDS, 2012, 7 (04) : 339 - 344
  • [27] A multicentre sero-behavioural survey for hepatitis B and C, HIV and HTLV among people who inject drugs in Germany using respondent driven sampling
    Zimmermann, Ruth
    Marcus, Ulrich
    Schaeffer, Dirk
    Leicht, Astrid
    Wenz, Benjamin
    Nielsen, Stine
    Santos-Hoevener, Claudia
    Ross, R. Stefan
    Stambouli, Oumaima
    Ratsch, Boris-Alexander
    Bannert, Norbert
    Bock, Claus-Thomas
    Kuecherer, Claudia
    Hamouda, Osamah
    BMC PUBLIC HEALTH, 2014, 14
  • [28] Integrated supervised consumption services and hepatitis C testing and treatment among people who inject drugs in Toronto, Canada: A cross-sectional analysis
    Greenwald, Zoe R.
    Bouck, Zachary
    McLean, Elizabeth
    Mason, Kate
    Lettner, Bernadette
    Broad, Jennifer
    Dodd, Zoe
    Nassau, Tanner
    Scheim, Ayden I. I.
    Werb, Dan
    JOURNAL OF VIRAL HEPATITIS, 2023, 30 (02) : 160 - 171
  • [29] Hepatitis C testing in general practice settings: A cross-sectional study of people who inject drugs in Australia
    Butler, Kerryn
    Day, Carolyn
    Sutherland, Rachel
    van Buskirk, Joe
    Breen, Courtney
    Burns, Lucinda
    Larney, Sarah
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2017, 47 : 102 - 106
  • [30] Reasons for Not Seeking Hepatitis C Treatment among People Who Inject Drugs
    Morris, Leith
    Selvey, Linda
    Williams, Owain
    Gilks, Charles
    Smirnov, Andrew
    SUBSTANCE USE & MISUSE, 2020, 56 (02) : 175 - 184
12345